Bench asks government to reach out to the women, think of an immediate alternative The Supreme Court on Wednesday set up a seven-member committee to look into the deplorable conditions of “widows/destitutes” living in Vrindavan and set an eight-week deadline to complete its report. The committee, headed by the chairman of the Mathura District Legal Services Authority, will prepare a list of the widows with their names, age and reasons for being...

-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...

Doctors across India who encounter patients with tuberculosis will have to disclose the identity, age, sex, and address of each patient to local health authorities under an order issued this week by the Union health ministry. The health ministry said today that it is essential to have complete information as part of its efforts to ensure that patients receive proper diagnosis and therapy and to curb the emergence and spread of...

-The Hindu The Centre on Tuesday unveiled the expanded version of the Mahatma Gandhi National Rural Employment Guarantee Act, allowing over 30 new permissible works, as productivity-enhancing activity. The gram panchayats alone have been empowered to decide on the priority of work to be taken up. Union Minister for Rural Development Jairam Ramesh, who tabled in Parliament a copy of the new notification, and Planning Commission member Mihir Shah told reporters that...

A report by a parliamentary committee has shown that the drug industry regulator, the Drug Controller General of India (DCGI), has been approving, on average, one new drug a month without conducting mandatory clinical trials or seeking expert medical opinion—findings that expose the deep flaws prevalent in India’s drug approval process. The committee has asked the health ministry to withdraw the discretionary powers given to the Central Drugs Standard Control Organization...